Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0PM5R
|
||||
| Former ID |
DIB018734
|
||||
| Drug Name |
AB-MECA
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [467502] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H21N7O4
|
||||
| InChI |
InChI=1S/C18H21N7O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-2-4-10(19)5-3-9/h2-5,7-8,12-14,18,26-27H,6,19H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1
|
||||
| InChIKey |
LDYMCRRFCMRFKB-MOROJQBDSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2b receptor | Target Info | Agonist | [534553] | |
| Adenosine A3 receptor | Target Info | Agonist | [525758] | ||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| References | |||||
| Ref 525758 | [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol. 2000 May;57(5):968-75. | ||||
| Ref 534553 | Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):1-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.